In the wake of the germline editing controversy, when Chinese scientist He Jianku illegally edited the embryos of human twins, the ethics of CRISPR therapy have had global attention. Many countries ...
YD Bio Limited ('YD Bio Ltd” or the 'Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations, today announced that ...
In-Orbit Manufacturing (IOM) is one subset of the wider In-Orbit Servicing, Assembly and Manufacturing (ISAM) market. It ...
Biopharma dealmaking continued its momentum into 2026, with January logging $31.16 billion in total value. That figure outpaced January 2025’s $28.63 billion and exceeded the 2025 monthly average of ...
CARLSBAD, CA, UNITED STATES, February 9, 2026 /EINPresswire.com/ — Cosmo Bio USA, a leading international distributor of life science research products, announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results